AptarGroup – Consensus Indicates Potential 25.5% Upside

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

AptarGroup with ticker code (ATR) have now 7 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 167 and 125 with the average target price sitting at 144.57. Now with the previous closing price of 115.19 this is indicating there is a potential upside of 25.5%. The 50 day MA is 119.38 and the 200 day MA is 131.61. The market capitalisation for the company is $7,587m. Company Website: https://www.aptar.com

The potential market cap would be $9,522m based on the market concensus.

AptarGroup provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active packaging products. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. The company was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search